Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant
- Status
- WITHDRAWN
- Phase
- NA
Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
- Status
- SUSPENDED
- Phase
- PHASE2
Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- NA
Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
VA vs DA for Newly Diagnosed Hig-risk AML
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
- Status
- TERMINATED
- Phase
- PHASE1
PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1 Study of BMF-500 in Adults With Acute Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission
- Status
- RECRUITING
- Phase
- NA
Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
- Status
- RECRUITING
- Phase
- PHASE2
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Telehealth Advance Care Planning Intervention
- Status
- RECRUITING
- Phase
- NA
RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
- Status
- RECRUITING
- Phase
- PHASE1
Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS
- Status
- WITHDRAWN
- Phase
- PHASE2